Parexel has introduced a new ecosystem of integrated data-driven services as the industry looks to gain better insights from myriad information sources.
LabCorp’s Covance has opened a new companion diagnostics laboratory as is prepares for an increasing demand for precision medicine – a market expected to reach $112.62bn by 2025.
At least 50,000 volunteers are needed to participate in clinical trials for Alzheimer’s disease – the global cost of which is expected to reach $2 trillion by 2030.
The global central laboratory and support services provider has secured a $24.5m Series A investment and is on track to double in size, again, over the next five years, says CEO.
In the first public application of its technology, Bitmark Inc. has partnered with the UC Berkeley School of Public Health to conduct studies using its blockchain technology.
Topstone Research has joined the Partner Program at Medrio, a Software as a Service (SaaS) company that provides electronic data capture (EDC) and eSource to clinical trials.
The international contract research organization (CRO) and non-profit organization have signed a three-year “teaming agreement” to advance clinical trials for gynecologic malignancies.
Rich Pharmaceuticals has selected a clinical trial site in Thailand at which it will conduct a Phase I/II trial in collaboration with the contract research organization (CRO) CMIC ASIA-PACIFIC, PTE. LTD. (CMIC).
Chiltern has acquired Integrated Development Associates Co. Ltd. (IDA), a Japenese contract research organization (CRO) with offices in Japan, Korea, and Southeast Asia.
The extended partnership provides CROS NT customers access to Medidata’s electronic data capture (EDC) solution as well as its randomization and trial supply management system (RTSM).
SGS has completed a Phase I clinical trial of a new influenza virus strain in healthy volunteers and has increased capacity at its Mississauga, Canada-based laboratory.
Proposed amendments to the European Medicines Agency’s (EMA) access to documents policy have been criticised by medicines watchdogs, including not-for-profit Health Action International and Prescrire.
LabCorp has completed its acquisition of Pathology Associates Medical Laboratories (PAML), which will be integrated into its national network of regional and specialty laboratories.
WIRB-Copernicus Group (WCG) has acquired MedAvante and ProPhase, bolstering the company’s presence in the central nervous system (CNS) and behavioral health assessment markets.
AB Science SA has halted French trials of its Ph III drug candidate masitinib after regulators uncovered good clinical practice (GCP) and pharmacovigilance deviations in an earlier study.
The full-service contract research organization (CRO) is moving to a new office in Boston, MA, which will serve at its fourth "hub," joining Berlin, Warsaw, and Kiev locations.
PRA Health Sciences has launched a new Center for Pediatric Clinical Development and a correlating site network to facilitate patient recruitment and improved engagement and retention.
Pharmaceutical Product Development, LLC (PPD) has combined its medical affairs research operations (MARO) team and Evidera to create a dedicated real-world research and market access unit.
The NIH-FDA Joint Leadership Council and TransCelerate BioPharma have issued updated common protocol templates (CPT) to accelerate clinical development.
The partnership helps accelerate site selection by enabling ACRP members to create a profile accessible to users of the DrugDev Spark Platform, the company’s unified clinical operations suite.
There are several opportunities for contract research organizations (CROs) to advance patient centricity and many are looking to do so over the next three years, according to a report.
WIRB-Copernicus Group (WIRB) and Huron have announced an alliance to support research programs in the face of heightened expectations from industry sponsors.
Schulman IRB has launched a new service to ensure sponsors, CROs, and others are compliant when conducting genetic engineering research – “given the diverse risks,” says committee lead.
QuintilesIMS has announced an alliance with Salesforce through which the companies aim to “equip and enable” customers to meet future healthcare challenges.
